The money raised from the UMass Medicine Cancer Walk, held on Sunday, Sept. 29, provides essential support to cancer researchers at UMass Medical School. In this video, Michelle Kelliher, PhD, professor of cancer biology, talks about finding new pathways that can lead to targeted therapies for the 20 percent of children with acute lymphocytic leukemia who don’t respond to conventional chemotherapy treatment.
“Efforts like those of the Cancer Walk are essential to support investigators like myself and our research programs. This is particularly true now more than ever because the NIH budget has been limited,” said Dr. Kelliher. “Several cancer researchers, who have very exciting research programs, are struggling to get funding. These initiatives help maintain the momentum that we’ve established in our research.”
Related links on UMassMedNow:
Jacob’s journey gives special meaning to UMass Medicine Cancer Walk
A full-circle journey for cancer survivor
Buy or service your car at Harr and support the UMass Medicine Cancer Walk
Homegrown teams strengthen UMass Medicine Cancer Walk
